EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,200 | -5.2% | 4,000 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $32,920 | +13.5% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $29,000 | -18.3% | 4,000 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $35,480 | -27.6% | 4,000 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $49,000 | +4.3% | 4,000 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $47,000 | +23.7% | 4,000 | +100.0% | 0.01% | +60.0% |
| Q1 2022 | $38,000 | -28.3% | 2,000 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $53,000 | -35.4% | 2,000 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $82,000 | +1071.4% | 2,000 | +627.3% | 0.01% | +1000.0% |
| Q1 2019 | $7,000 | – | 275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |